PubMed Health⌕ Search

Biomedical subjects

J H Mendelson

Publications and source records attributed to J H Mendelson.

At least 199 records · Page 11Linked to original sources

Buprenorphine self-administration by rhesus monkey.

Intravenous injections of buprenorphine, a partial opiate agonist and antagonist, maintained operant responding under second order schedule control (FR 3 VR 16:S) across a dose range of 0.005 to 0.10 mg/kg/inj. A drug naive monkey and four monkeys with a history of morphine self-administration all self-administered buprenorphine at all doses studied. Four monkeys showed dose-related increases in the total amount of buprenorphine (mg/kg) self-administered each day as the available dose increased from 0.01 to 0.10 mg/kg/inj. Injections per day remained equivalent to the number of injections at the lowest dose studied or increased significantly (p less than 0.05, 0.01), as the dose per injection increased in three monkeys. Even at high buprenorphine doses, there was no evidence of sedation. Monkeys consistently self-administered significantly more buprenorphine than saline in control studies (p less than 0.01). Buprenorphine's agonistic effects appear to persist for 24 to 48 hours. When saline and buprenorphine were available on alternate days, monkeys did not distinguish between them, but when 3 days of saline were alternated with 1 day of buprenorphine (0.03 mg/kg/inj), monkeys took significantly more buprenorphine than saline (p less than 0.02--0.001). Abrupt discontinuation of buprenorphine (0.10 mg/kg/inj) did not result in discernible withdrawal signs. The effects of buprenorphine on food intake were inconsistent, but there were no significant changes in body weight as a function of chronic buprenorphine self-administration or withdrawal. These data indicate that buprenorphine is a positive reinforcer in rhesus monkeys and maintains behavior leading to its administration on second order schedules over a wide dose range. Despite its opiate agonist properties, there was no evidence of physical dependence.

Animals↗

Pulmonary dysfunction in cocaine smokers.

The authors report another complication of freebase cocaine smoking. They found a significant reduction in the carbon monoxide diffusing capacity in the lungs of two patients. This suggests that inhalation of the freebase of cocaine may damage the pulmonary gas exchange surface.

Adult↗

Acute alcohol intake and pituitary gonadal hormones in normal human females.

Plasma prolactin, luteinizing hormone and estradiol levels were determined in six normal adult females before and during a period of acute alcohol intoxication. Plasma hormone levels found in these studies were compared with values obtained after administration of an isocaloric beverage. Each woman served as her own control for both studies which were carried out on the same day of the menstrual cycle (day 8, 9 or 10) over two consecutive menstrual cycles. Integrated plasma samples were obtained every 20 min for 6 consecutive hr before acute alcohol administration and during the ascending, peak and descending portions of the blood alcohol curve. After acute alcohol administration, all women achieved a moderate degree of intoxication, with mean peak blood alcohol levels of 88 mg/100 ml. No significant differences in levels of luteinizing hormone and estradiol were detected during any phase of the blood alcohol curve when compared to prealcohol administration values. No significant differences were found between luteinizing hormone and estradiol after alcohol administration when compared with values obtained after isocaloric beverage. The only significant difference in hormone levels was a small elevation in prolactin during the descending phase of the blood alcohol curve when nausea and vomiting coincident with alcohol-induced intoxication occurred. These data contrast sharply with the significant effects of acute alcohol intake on pituitary gonadal hormones in normal human males.

Adult↗

Operant analysis of human heroin self-administration and the effects of naltrexone.

The effects of maintenance on a narcotic antagonist, naltrexone (50 mg/day p.o.), or placebo on patterns of operant acquisition and use of heroin were studied under double-blind conditions. Twelve male heroin addict volunteers lived on a clinical research ward for 34 days. After a 9 day drug-free period, naltrexone or placebo were given and heroin) 40 mg/day) was available for 10 days. Subjects could earn money ($1.50) or heroin (10 mg i.v.) by responding on a second-order schedule of reinforcement [FR 300 (FI 1 sec: S)] for approximately 90 min. The three naltrexone-maintained subjects took only 2 to 7.5% of the total heroin available. Two naltrexone subjects stopped heroin self-administration after the 1st or 2nd heroin injection; the third subject took a 3rd heroin injection on the 8th day of heroin availability. Naltrexone maintenance for 25 consecutive days did not produce adverse side effects. In contrast, the nine placebo naltrexone subjects used 57.5 to 100% of the total heroin available. Five placebo subjects used all or all but one of the 40 injections available; four placebo subjects often used less heroin than was available each day. Heroin intoxication did not impair operant performance. Heroin users worked longer hours and earned more purchase points (P < .05) during heroin self-administration and subsequent methadone detoxification than during the drug-free period. Subjects precisely titrated operant work to acquire the desired amount of heroin, then resumed working for money. These data demonstrate the feasibility of using direct measures of drug self-administration behavior to evaluate new pharmacotherapies for heroin abuse and indicate the effectiveness of naltrexone in suppressing heroin self-administration.

Adult↗

Buprenorphine suppresses heroin use by heroin addicts.

Heroin-dependent men were given buprenorphine (a partial opiate agonist-antagonist) or a placebo under duoble-blind conditions on a clinical research ward where they could acquire heroin (21 to 40.5 milligrams per day, intravenously). Buprenorphine significantly (P less than .001) suppressed the self-administration of heroin over 10 days. Control subjects took between 93 and 100 percent of the available heroin. The effects of buprenorphine were dose-dependent; a dose of 8 milligrams per day reduced heroin use by 69 to 98 percent; a dose of 4 milligrams per day reduced heroin use by 45 percent. Termination of buprenorphie maintenance did not result in opiate withdrawal signs or symptoms. The subjects liked buprenorphine and indicated that it was preferable to methadone or naltrexone. Buprenorphine should be a safe and effective new pharmacotherapy for heroin dependence.

Adult↗

Effects of heroin self-administration on cigarette smoking.

Cigarette smoking increased during heroin self-administration in comparison to drug-free and methadone detoxification conditions in eight heroin addicts given naltrexone placebo (P less than 0.01) and three heroin addicts given buprenorphine placebo. Cigarette smoking was stable across conditions for one subject who did not use heroin during naltrexone blockade of heroin effects. Five subjects smoked significantly more (P less than 0.01) during the hour following a heroin injection than during the preceding hour, and two subjects in the same group smoked significantly less following a heroin injection (P less than 0.05). Subjects smoked significantly more during the evening and night when self-administering heroin than during baseline conditions (P less than 0.05), but subjects did not sleep significantly less during heroin self-administration. The peak of the intercigarette interval distribution remained between 16-30 min during baseline and heroin conditions. However, the increased smoking during heroin use appeared to reflect a higher rate of smoking rather than a generalized increase across intercigarette intervals. These data extend previous findings, that alcohol consumption is associated with increased cigarette smoking, to IV heroin self-administration.

Adult↗

Effect of acute ethanol ingestion on integrated plasma prolactin levels in normal men.

Healthy male subjects ingested 1.0 g ethanol/kg (Alcohol Day) and caloric equivalents of sucrose (Control Day). Plasma prolactin was determined on samples collected at 20-min intervals by serial constant blood exfusion, from 2 hr before to 4 hr after the drink. In 14 of the 15 men studied, plasma prolactin levels during the 2-hr period after alcohol administration were elevated an average of 31% above values for the preceding 2-hr period. Data pooled for all subjects revealed a small but statistically significant increase in prolactin coinciding with ascending and peak concentrations of blood alcohol. A significant increment in prolactin was associated with peak blood alcohol levels when values were compared between control and alcohol treatment days. Although of statistical significance, these transient and variable increases were within the normal range of basal prolactin levels for most subjects and are unlikely to be physiologically meaningful.

Adult↗

Effects of heroin and naltrexone on plasma prolactin levels in man.

Plasma levels of prolactin were increased following intravenous self-administration of heroin by young men with a history of heroin addiction. Following 10 days of controlled heroin usage, tolerance could be demonstrated to the acute prolactin-releasing effect of heroin. There was no evidence that a single dose of naltrexone affected basal prolactin levels.

Adult↗

Effect of alcohol and marihuana on tobacco smoking.

Tobacco smoking covaried with alcohol consumption in male social drinkers over 15 days of unrestricted alcohol availability. Increased tobacco smoking was associated with alcohol consumption in occasional, moderate, and heavy smokers. Tobacco smoking was not systematically related to marihuana smoking even though both drugs were often smoked at the same time. During ten days of concurrent access to tobacco, alcohol, and marihuana, tobacco smoking continued to covary with alcohol consumption rather than with marihuana smoking. Marihuana smoking appeared to be independent of alcohol consumption patterns.

Adult↗

Opiate use and sexual function.

Although opiate addicts often equate the drug experience with sexual orgasm, diminished libido and impaired sexual performance are common sequelae of chronic use. Early clinical studies suggested that opiates may interfere with sex hormone secretion. The authors carried out three sequential studies which demonstrated that heroin use in man results in acute suppression of luteinizing hormone (LH) release from the pituitary followed by a secondary drop in plasma testosterone levels. The time course of these neuroendocrine events correlates well with the tension-reducing effects of heroin and suggests that drive reduction is an important component of opiate reinforcement.

Erectile Dysfunction↗

Heroin and naltrexone effects on pituitary-gonadal hormones in man: interaction of steroid feedback effects, tolerance and supersensitivity.

The acute and chronic effects of heroin, and the opiate antagonist naltrexone, on integrated plasma samples analyzed for luteinizing hormone (LH) and testosterone (T) levels were studied in six adult males with a history of heroin addiction. Acute doses of heroin (10 mg i.v.) significantly suppressed LH levels. Chronic heroin use was also associated with a significant decrease in plasma T levels. LH levels after chronic heroin use were lower than control levels but the degree of LH suppression was approximately the same as after the acute doses of heroin. Acute naltrexone administration did not alter T levels appreciably but was associated with a significant elevation in LH levels. After 22 days of chronic naltrexone maintenance, T levels were in the high normal range and LH levels were in the low normal range. These data suggest the development of tolerance and supersensitivity to opiate agonist and antagonist effects on pituitary-gonadal hormones involves interaction between the direct effects of these drugs on LH followed by steroid feedback effects of T on gonadotrophin secretory activity.

Adult↗

Effects of the neuropeptide DG-AVP on morphine and food self-administration by dependent rhesus monkey.

Pretreatment with the neuropeptide DG-AVP (desglycrinamide9-arginine8-vasopressin) at two dose levels (25 and 125 mcg/kg) did not reduce intravenous morphine self-administration (0.25 mg/kg/inj) by morpine dependent monkeys, in comparison to pretreatment with saline or DG-AVP vehicle placebo. Food self-administration was also unaffected by DG-AVP pretreatment in comparison to control conditions. These data do not confirm previous reports of a dose-dependent suppression of heroin self-administration in rat following DG-AVP pretreatment [14].

Animals↗